ArticleThe Journal of biological chemistry2022

Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression.

DeannaLee M Beauvais et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.